|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/51 | |
| A61K 39/00 | |||
| A61K 39/39 | |||
| A61P 37/04 | |||
| A61P 35/00 | |||
| A61P 31/00 |
| (11) | Patento numeris | 1954252 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 06851781.2 |
| Europos patento paraiškos padavimo data | 2006-12-01 | |
| (97) | Europos patento paraiškos paskelbimo data | 2008-08-13 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-02-03 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2006/046212 |
| Data | 2006-12-01 |
| (87) | Numeris | WO 2008/051245 |
| Data | 2008-05-02 |
| (30) | Numeris | Data | Šalis |
| 741860 P | 2005-12-02 | US | |
| 775265 P | 2006-02-21 | US |
| (72) |
WENDORF, Janet R., US
SINGH, Manmohan, US
O`HAGAN, Derek T., US
|
| (73) |
GlaxoSmithKline Biologicals SA,
Rue de l`Institut 89, 1330 Rixensart,
BE
|
| (54) | NANOPARTICLES FOR USE IN IMMUNOGENIC COMPOSITIONS |
| NANOPARTICLES FOR USE IN IMMUNOGENIC COMPOSITIONS |